Prediction of Clinical Outcomes with Explainable Artificial Intelligence in Patients with Chronic Lymphocytic Leukemia
Joerg Hoffmann(Philipps University of Marburg), Cornelia Brendel(Philipps University of Marburg), Andreas Neubauer(RWTH Aachen University), Michael C. Thrun(Philipps University of Marburg), Alfred Ultsch(Philipps University of Marburg), Stefan W. Krause(Universitätsklinikum Erlangen), Christian Wilhelm(Philipps University of Marburg), Semil Eminovic(Universitätsklinikum Gießen und Marburg)
Cited by 13
Related Papers
Diverse Applications of Nanomedicine
|ACS Nano|2017|1.4k
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Immunochemotherapy With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Significantly Improves Response and Time to Treatment Failure, But Not Long-Term Outcome in Patients With Previously Untreated Mantle Cell Lymphoma: Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG)
|Journal of Clinical Oncology|2005|573